Total Payments
$944,018
2024 Payments
$73,706
Companies
56
Transactions
1,856
Medicare Patients
4,266
Medicare Billing
$619,708
Payment Breakdown by Category
Other$764,849 (81.0%)
Travel$121,198 (12.8%)
Consulting$30,940 (3.3%)
Food & Beverage$26,675 (2.8%)
Education$296.31 (0.0%)
Gifts$59.40 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $763,549 | 467 | 80.9% |
| Travel and Lodging | $121,198 | 299 | 12.8% |
| Consulting Fee | $30,940 | 12 | 3.3% |
| Food and Beverage | $26,675 | 1,063 | 2.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,300 | 1 | 0.1% |
| Education | $296.31 | 13 | 0.0% |
| Gift | $59.40 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $529,928 | 802 | $0 (2024) |
| Novo Nordisk Inc | $299,420 | 372 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $50,151 | 102 | $0 (2024) |
| Amarin Pharma Inc. | $20,538 | 37 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $15,593 | 76 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $12,374 | 45 | $0 (2020) |
| Insulet Corporation | $8,240 | 54 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,645 | 13 | $0 (2024) |
| Abbott Laboratories | $679.00 | 42 | $0 (2024) |
| Amgen Inc. | $623.14 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $73,706 | 167 | Lilly USA, LLC ($66,711) |
| 2023 | $43,803 | 144 | Lilly USA, LLC ($27,392) |
| 2022 | $118,663 | 201 | Lilly USA, LLC ($64,551) |
| 2021 | $12,684 | 103 | Lilly USA, LLC ($7,451) |
| 2020 | $78,439 | 188 | Novo Nordisk Inc ($34,906) |
| 2019 | $139,604 | 276 | Lilly USA, LLC ($91,935) |
| 2018 | $206,827 | 337 | Lilly USA, LLC ($98,814) |
| 2017 | $270,292 | 440 | Lilly USA, LLC ($140,692) |
All Payment Transactions
1,856 individual payment records from CMS Open Payments — Page 1 of 75
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: DIABETES | ||||||
| 12/02/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $24.93 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Endocrinology | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: Diabetes Care | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $938.00 | General |
| Category: Diabetes | ||||||
| 10/22/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Diabetes Care | ||||||
| 10/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Endocrinology | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $21.84 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 10/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 942 | 1,733 | $430,543 | $141,481 |
| 2022 | 13 | 1,023 | 1,930 | $477,455 | $154,559 |
| 2021 | 16 | 1,156 | 2,177 | $548,019 | $177,754 |
| 2020 | 17 | 1,145 | 2,114 | $534,044 | $145,915 |
Total Patients
4,266
Total Services
7,954
Medicare Billing
$619,708
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 469 | 1,152 | $298,368 | $100,638 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 94 | 94 | $37,412 | $10,990 | 29.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 116 | 119 | $32,725 | $10,174 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 109 | $19,075 | $6,888 | 36.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 67 | 141 | $15,087 | $3,642 | 24.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 19 | 19 | $5,301 | $2,469 | 46.6% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 21 | 21 | $7,077 | $2,211 | 31.2% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 16 | 16 | $6,208 | $1,595 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,662 | $1,255 | 26.9% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 16 | 16 | $3,312 | $1,132 | 34.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 14 | 28 | $1,316 | $486.20 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 451 | 1,187 | $307,433 | $103,499 | 33.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 97 | 97 | $38,606 | $11,673 | 30.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 110 | 111 | $30,525 | $9,312 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 66 | 66 | $18,414 | $8,676 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 77 | 93 | $16,275 | $5,451 | 33.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 61 | 142 | $15,194 | $3,883 | 25.6% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 41 | 54 | $19,716 | $3,737 | 19.0% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 23 | 26 | $8,762 | $2,570 | 29.3% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2022 | 42 | 43 | $8,901 | $2,365 | 26.6% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 16 | 71 | $3,337 | $1,331 | 39.9% |
| 10006 | Fine needle aspiration biopsy using ultrasound guidance, each additional growth | Office | 2022 | 15 | 16 | $5,392 | $774.02 | 14.4% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 13 | 13 | $3,250 | $746.85 | 23.0% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2022 | 11 | 11 | $1,650 | $540.43 | 32.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 447 | 1,318 | $341,362 | $120,748 | 35.4% |
About Dr. Israel Hartman, M.D
Dr. Israel Hartman, M.D is a Specialist healthcare provider based in Arlington, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437217536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Israel Hartman, M.D has received a total of $944,018 in payments from pharmaceutical and medical device companies, with $73,706 received in 2024. These payments were reported across 1,856 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($763,549).
As a Medicare-enrolled provider, Hartman has provided services to 4,266 Medicare beneficiaries, totaling 7,954 services with total Medicare billing of $619,708. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Arlington, TX
- Active Since 12/04/2006
- Last Updated 11/19/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437217536
Products in Payments
- TRULICITY (Drug) $262,582
- MOUNJARO (Drug) $141,066
- Ozempic (Drug) $114,204
- JARDIANCE (Drug) $74,319
- Tresiba (Drug) $63,809
- Rybelsus (Drug) $41,404
- Victoza (Drug) $37,913
- BASAGLAR (Drug) $35,233
- Vascepa (Drug) $20,538
- FARXIGA (Drug) $15,376
- RYBELSUS (Drug) $13,261
- INVOKANA (Drug) $12,346
- Xultophy 100/3.6 (Drug) $9,167
- Omnipod (Device) $8,240
- CYCLOSET (Drug) $1,673
- AFREZZA (Drug) $567.42
- FREESTYLE LIBRE (Device) $507.29
- Saxenda (Drug) $453.52
- t-slim insulin pump (Device) $413.63
- BAQSIMI (Drug) $378.75
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Arlington
Dr. Gerard Engh, M.d, M.D
Specialist — Payments: $215,702
Specialist $215,702
Dr. Corey Wallach, Md, MD
Specialist — Payments: $115,045
Specialist $115,045
Bhasker Mehta, Md, MD
Specialist — Payments: $39,798
Specialist $39,798
Dr. Robert Christie, M.d, M.D
Specialist — Payments: $17,207
Specialist $17,207
Dr. Patricia Rodriguez, M.d, M.D
Specialist — Payments: $11,339
Specialist $11,339
Rusty Milhoan, Md, MD
Specialist — Payments: $9,272
Specialist $9,272